FIELD: medicine.
SUBSTANCE: method involves homogenization of actinia Heteractis crispa, ethanol extraction of polypeptides, polychrome-1 hydrophobic chromatography, following purification of an end product by ion-exchange chromatography and reverse phase HPLC. Polychrome-1 hydrophobic chromatography is conducted in a static version, while ion-exchange chromatography is conducted on Cellulose CM-32.
EFFECT: end product yield higher in 12 times.
2 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ACTINIA POLYPEPTIDE, POSSESSING ANALGESIC ACTION | 2009 |
|
RU2404245C1 |
| ACTINIA POLYPEPTIDE HAVING ANALGETIC ACTION | 2008 |
|
RU2368621C1 |
| POLYPEPTIDE FROM SEA ANEMONE HETERACtis crispa, HAVING ANALGESIC ACTION | 2012 |
|
RU2475497C1 |
| POLYPEPTIDE FROM HETERACTIS MAGNIFICA SEA ANEMONE INHIBITING MAMMALIAN Α-AMYLASES AND ITS USE AS AN INHIBITOR OF MAMMALIAN Α-AMYLASES, AS WELL AS AGENTS FOR THE TREATMENT AND/OR PREVENTION OF POSTPRANDIAL HYPERGLYCEMIA, CORRECTION OF OVERWEIGHT AND OBESITY | 2022 |
|
RU2796823C1 |
| RECOMBINANT PLASMID DNA PSMT3_HCRG21 ENCODING A HYBRID PROTEIN SMT3-HCRG21, BACTERIAL STRAIN ESCHERICHIA COLI BL21(DE3)/PSMT3_HCRG21 - PRODUCER OF HCRG21 ANALGESIC PEPTIDE AND METHOD OF PRODUCING RECOMBINANT HCRG21 ANALGESIC PEPTIDE | 2022 |
|
RU2798545C1 |
| METHOD OF PREPARING PROTEIN INHIBITORS OF GLUCANASES | 1999 |
|
RU2162708C1 |
| AGENT POSSESSING INHIBITORY CAPACITY WITH RESPECT TO HUMAN IMMUNODEFICIENCY VIRUS REVERSE TRANSCRIPTASE | 2006 |
|
RU2314818C1 |
| METHOD OF PREPARING OVOINHIBITOR | 1997 |
|
RU2129438C1 |
| RECOMBINANT PLASMID DNA pMSIN4, CODING HYBRIDE POLYPEPTIDE - HUMAN INSULIN PRECURSOR, BL21(DE3)VpMSIN4-PRODUCER STRAIN OF RECOMBINANT HUMAN INSULIN, METHOD FOR PRODUCING RECOMBINANT HUMAN INSULIN | 2011 |
|
RU2447149C1 |
| METHOD OF PRODUCING A PEPTIDE WHICH MODULATES PURINERGIC RECEPTOR ACTIVITY | 2019 |
|
RU2714114C1 |
